Israel Englander Ligand Pharmaceuticals Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $1.41 Million - $1.84 Million	20,600 Added 127.08%	36,810 $2.69 Million
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $803,529 - $1.18 Million	16,210 New	16,210 $1.16 Million
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $11 Million - $12.9 Million	-167,611 Reduced 79.96%	41,996 $3.09 Million
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $2.68 Million - $4.2 Million	43,390 Added 26.1%	209,607 $14 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $868 - $9.34 Million	86,807 Added 109.31%	166,217 $14.3 Million
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $3.84 Million - $6.04 Million	-51,593 Reduced 39.38%	79,410 $7.09 Million
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $117,882 - $188,085	-1,241 Reduced 0.94%	131,003 $14.7 Million
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $5.43 Million - $7.05 Million	42,495 Added 47.35%	132,244 $20.4 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $10.4 Million - $14.8 Million	-102,083 Reduced 53.21%	89,749 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $5.63 Million - $7.75 Million	49,785 Added 35.05%	191,832 $25.2 Million
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $12.9 Million - $27.9 Million	129,321 Added 1016.2%	142,047 $21.7 Million
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $1.47 Million - $1.94 Million	-18,276 Reduced 58.95%	12,726 $1.27 Million
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $3.39 Million - $4.79 Million	-37,828 Reduced 54.96%	31,002 $2.96 Million
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $4.6 Million - $8.33 Million	-67,403 Reduced 49.48%	68,830 $7.7 Million
Q1 2020 May 14, 2020	BUY	$63.37 - $107.88 $7.26 Million - $12.4 Million	114,617 Added 530.24%	136,233 $9.91 Million
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $274,340 - $321,459	2,830 Added 15.06%	21,616 $2.25 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $201,738 - $281,054	-2,339 Reduced 11.07%	18,786 $1.87 Million
Q2 2019 Aug 15, 2019	SELL	$107.38 - $129.34 $18.5 Million - $22.2 Million	-172,008 Reduced 89.06%	21,125 $2.41 Million
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $19.9 Million - $23.9 Million	185,005 Added 2276.14%	193,133 $12.9 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $57.1 Million - $76.8 Million	-538,829 Reduced 98.51%	8,128 $1.02 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $57.9 Million - $123 Million	450,791 Added 468.76%	546,957 $74.2 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $20.3 Million - $26.4 Million	96,166 New	96,166 $26.4 Million
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $479,105 - $631,134	-3,456 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $443,612 - $508,170	3,456	3,456 $473,000

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account